From the Cloud to the Clinic, Wide Range of St. Jude Research Presented at AACR 2018

The 2018 American Association for Cancer Research (AACR) Annual Meeting features research, resources and expertise from St. Jude Children’s Research Hospital
12-Apr-2018 4:15 PM EDT Add to Favorites

St. Jude Cloud, Largest Public Repository of Pediatric Cancer Genomics Data, Launches for Researchers Worldwide

St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases.
11-Apr-2018 8:05 PM EDT Add to Favorites

Neurocognitive Risk May Begin Before Treatment for Young Leukemia Patients

Chemotherapy agents have been associated with neurocognitive side effects in young leukemia survivors. Now St. Jude Children’s Research Hospital scientists have evidence the disease and genetics might also play a role.
27-Mar-2018 4:05 PM EDT Add to Favorites

Many Adolescent and Young Adult Cancer Survivors Have More Social Connections Than Peers

St. Jude Children’s Research Hospital scientists have developed a new method to measure social networks of survivors of adolescent and young adult cancer in order to cultivate the health benefits of social connections
6-Mar-2018 11:05 AM EST Add to Favorites

Genomic Analysis Underscores Need for Precision Therapies That Target Pediatric Cancer

Research led by St. Jude Children’s Research Hospital offers the most comprehensive analysis yet of the genomic alterations leading to cancer in children and affirms the need for pediatric-specific precision therapies
23-Feb-2018 4:00 PM EST Add to Favorites

Effective Pediatric Cancer Treatment Is Possible in the Midst of a Refugee Crisis

Six years into Lebanon’s refugee crisis, St. Jude Children’s Research Hospital and the Children’s Cancer Center of Lebanon at the American University of Beirut Medical Center offer a blueprint for effective childhood cancer treatment during...
26-Feb-2018 5:05 PM EST Add to Favorites

‘Hijacker’ Drives Cancer in Some Patients with High-Risk Neuroblastoma

Researchers in Memphis and Boston have collaborated to show c-MYC is an oncogene that drives neuroblastoma in some high-risk patients; the findings help set the stage for much-needed precision medicines
22-Jan-2018 5:05 PM EST Add to Favorites

Researchers Discover That a “Muscle” Cancer Is Not Really a Muscle Cancer

St. Jude Children’s Research Hospital oncologists have discovered the cell type that gives rise to rhabdomyosarcoma, the most prevalent soft tissue cancer in children. Previously, scientists thought the cancer arose from immature muscle cells,...
8-Jan-2018 11:00 AM EST Add to Favorites

see all news